Meta-Analysis of Drug-Eluting Balloon Angioplasty and Drug-Eluting Stent Placement for Infrainguinal Peripheral Arterial Disease

Hirsch, 2001, Peripheral arterial disease detection, awareness, and treatment in primary care, JAMA, 286, 10.1001/jama.286.11.1317 Jens, 2014, Randomized trials for endovascular treatment of infrainguinal arterial disease: systematic review and meta-analysis (part 1: above the knee), European Journal of Vascular and Endovascular Surgery., 47, 524, 10.1016/j.ejvs.2014.02.011 Romiti, 2008, Meta-analysis of infrapopliteal angioplasty for chronic limb ischemia, J Vasc Surg., 47, 975, 10.1016/j.jvs.2008.01.005 Y, 2008, Percutaneous transluminal angioplasty (PTA) alone versus PTA with balloon-expandable stent placement for short-segment femoropopliteal disease: a metaanalysis of randomized trials, J Vasc Interv Radiol, 19, 499, 10.1016/j.jvir.2007.12.446 Katsanos, 2014, Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery, J Vasc Surg., 59, 1123, 10.1016/j.jvs.2014.01.041 Park, 2003, A paclitaxel-eluting stent for the prevention of coronary restenosis, N Engl J Med., 348, 1537, 10.1056/NEJMoa021007 Yu, 2013, Drug-eluting balloons for coronary artery disease: a meta-analysis of randomized controlled trials, Int J Cardiol., 168, 197, 10.1016/j.ijcard.2012.09.094 Nararese, 2013, Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis, BMJ, 347, f6530, 10.1136/bmj.f6530 Lupi, 2013, Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: insights from a meta-analysis of 1462 patients, Int J Cardiol., 168, 4608, 10.1016/j.ijcard.2013.07.161 Wang, 2014, Meta-analysis of drug-eluting versus bare metal stents in patients with indications for oral anticoagulation undergoing coronary stenting, Acta Cardiol., 69, 237, 10.1080/AC.69.3.3027825 Gyongyosi, 2013, Effect of drug-coated balloon on porcine peripheral arteries: physiologic vascular function, safety and efficacy experiments, Presented at: EuroPCT Higgins, 2011, The Cochrane Collaboration’s tool for assessing risk of bias in randomized trials, BMJ, 343, d5928, 10.1136/bmj.d5928 Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 336, 924, 10.1136/bmj.39489.470347.AD Biostat. Comprehensive Meta Analysis, version 2.0. Available at www.meta-analysis.com. Accessed October 13, 2014. Borenstein, 2009 Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 Siablis, 2014, Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial, JACC Cardiovasc Interv, 7, 1048, 10.1016/j.jcin.2014.04.015 Fanelli, 2012, Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial, J Endovasc Ther., 19, 571, 10.1583/JEVT-12-3926MR.1 Liistro, 2013, Drug-eluting balloon in peripheral intervention for the superficial femoral artery, JACC: Cardiovascular Interventions, 6, 1295, 10.1016/j.jcin.2013.07.010 Scheinert, 2014, The LEVANT I (Lutonix Paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization, JACC: Cardiovascular Interventions, 7, 10, 10.1016/j.jcin.2013.05.022 Tepe, 2008, Local delivery of Paclitaxel to inhibit restenosis during angioplasty of the leg, N Engl Med, 358, 689, 10.1056/NEJMoa0706356 Werk, 2012, Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial, Circ Cardiovasr Interv, 5, 831, 10.1161/CIRCINTERVENTIONS.112.971630 Werk, 2008, Inhibition of restenosis in femoropopliteal arteries: Paclitaxel-coated versus uncoated balloon: femoral Paclitaxel randomized pilot trial, Circulation, 118, 1358, 10.1161/CIRCULATIONAHA.107.735985 Liistro, 2013, Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia, Circulation, 128, 615, 10.1161/CIRCULATIONAHA.113.001811 Gandini, 2013, Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study, J Endovasc Ther., 20, 805, 10.1583/13-4308MR.1 Dake, 2011, Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results, Circ Cardiovasc Interv, 4, 495, 10.1161/CIRCINTERVENTIONS.111.962324 Dake, 2013, Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions, JACC, 61, 2417, 10.1016/j.jacc.2013.03.034 Duda, 2006, Drug-eluting and bare Nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial, J Endovasc Ther., 13, 701, 10.1583/05-1704.1 Duda, 2002, Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results, Circulation, 106, 1505, 10.1161/01.CIR.0000029746.10018.36 Duda, 2005, Sirolimus-eluting versus bare Nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II Trial, J Vasc Interv Radiol, 16, 331, 10.1097/01.RVI.0000151260.74519.CA Rastan, 2012, Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents, JACC, 60, 587, 10.1016/j.jacc.2012.04.035 Rastan, 2011, Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre randomized clinical trial, European Heart Journal., 32, 2274, 10.1093/eurheartj/ehr144 Scheinert, 2012, A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the Sirolimus-eluting stent in patients with ischemic peripheral arterial disease, JACC, 60, 2290, 10.1016/j.jacc.2012.08.989 Tepe, 2010, Drug etluting stents versus PTA with GP IIb/IIIA blockage below the knee in patients with current ulcers – the BELOW study, J Cardiovasc Surg., 51, 203 Falkowski, 2009, The evaluation of primary stenting of sirolimus-eluting versus bare-metal stents in the treatment of atherosclerotic lesions of crural arteries, Eur Radiol, 19, 966, 10.1007/s00330-008-1225-1 Bosiers, 2012, Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease, J Vasc Surg., 55, 390, 10.1016/j.jvs.2011.07.099 Gandini, 2013, Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study, J Endovasc Ther, 20, 805, 10.1583/13-4308MR.1 Thomas, 2014, Vasculitis resulting from a superficial femoral artery angioplasty with a paclitaxel-eluting balloon, J Vasc Surg., 59, 520, 10.1016/j.jvs.2013.03.013 Freyhardt, 2011, Plasma levels following application of paclitaxel-coated balloon catheters in patients with stenotic or occluded femoropopliteal arteries, Rofo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 183, 448, 10.1055/s-0029-1246028 De Vries, 2013, First- and second-generation drug-eluting balloons for femoro-popliteal arterial obstructions: Update of technique and results, J Cardiovasc Surg., 54, 327 Habib, 2013, Metformin impairs endothelialization after placement of newer generation drug eluting stents, Atherosclerosis, 229, 385, 10.1016/j.atherosclerosis.2013.06.001 Rha, SW, Chen, KY, Oh, DJ, et al. Impact of heterogeneous overlapping drug-eluting stents on the arterial responses of rabbit iliac arteries: a comparison with overlapping bare metal stents. Korean Circ J. 42: 397-495. Zhao, 2012, Inhibition of experimental neointimal hyperplasia and neoatherosclerosis by local, stent-mediated delivery of everolimus, J Vasc Surg., 56, 1680, 10.1016/j.jvs.2012.04.022 Cassese, 2012, Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: A meta-analysis of randomized trials, Circulation: Cardiovascular Interventions, 5, 582 Rastan, 2012, Drug-eluting stents for treatment of focal infrapopliteal lesions, Vasa – Journal of Vascular Diseases, 41, 90, 10.1024/0301-1526/a000170 Katsanos, 2013, Systematic review of infrapopliteal drug-eluting stents: A meta-analysis of randomized controlled trials, Cardiovasc Interv Radiol, 36, 645, 10.1007/s00270-013-0578-2 Razavi, 2014, Contemporary systematic review and meta-analysis of early outcomes with percutaneous treatment for infrapopliteal atherosclerotic disease, J Vasc Interv Radiol, 25, 1489, 10.1016/j.jvir.2014.06.018 Fusaro, 2013, Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials, JACC Cardiovasc Interv, 6, 1284, 10.1016/j.jcin.2013.08.007 Diehm, 2013, Cost-effectiveness analysis of paclitaxel-coated balloons for endovascular therapy of femoropopliteal arterial obstructions, Journal of Endovascular therapy, 20, 819, 10.1583/13-4416R.1 Katsanos, 2013, Cost-effectiveness analysis of infrapopliteal drug-eluting stents, Cardiovasc Interv Radiol, 36, 90, 10.1007/s00270-012-0370-8 Ansel, 2013, The Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease: 4-year results, Presented at Vascular interventional advances (VIVA) Sacks, 2003, Reporting Standards for clinical evaluation of new peripheral arterial revascularization devices, J Vasc Interv Radiol, 14, S395, 10.1097/01.RVI.0000094613.61428.a9 Itani, 2013, First use of a drug-eluting balloon in the treatment of acute renal artery occlusion and in-stent restenosis, Am J Med Sci., 346, 244, 10.1097/MAJ.0b013e31828b2b7f Agarwal, 2013, Chronic total occlusion and successful drug-eluting stent placement in takayasu arteritis-induced renal artery stenosis, Clin Med Res, 11, 233, 10.3121/cmr.2013.1132 Sgueglia, 2014, Vascular imaging balloon with local drug delivery for the treatment of renal artery recurrent in-stent restenosis, Cardiovasc Revasc Med, 15, 186, 10.1016/j.carrev.2013.10.006 Veroux, 2013, Primary balloon angioplasty of small (≤2 mm) cephalic veins improves primary patency of arteriovenous fistulae and decreases reintervention rates, J Vasc Surg., 57, 131, 10.1016/j.jvs.2012.07.047 Krokidis, 2013, Peripheral applications of drug-coated balloons: Past, present and future, Cardiovasc Intervent Radiol., 36, 281, 10.1007/s00270-012-0467-0